Truvestments Capital’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
MIM
CCA
BFG
Truvestments Capital's BBH Position: Q1 2026 in Review
Truvestments Capital held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 220 shares worth $41.4K. The position accounts for 0.01% of the portfolio, ranked #525.
Truvestments Capital first reported a position in BBH in Q2 2019 and has held it in 23 quarters since. The position peaked at $51K in Q3 2021. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.
- Truvestments Capital held 220 shares of VanEck Biotech ETF worth $41.4K as of Q1 2026.
- Truvestments Capital left its VanEck Biotech ETF share count unchanged in Q1 2026.
- VanEck Biotech ETF made up 0.01% of Truvestments Capital's portfolio in Q1 2026, its #525 holding.
- Truvestments Capital first reported a position in VanEck Biotech ETF in Q2 2019 and has held it in 23 quarters since.
- Truvestments Capital's VanEck Biotech ETF position peaked at $51K in Q3 2021.
- 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.
Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.